Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20852, USA.
Best Pract Res Clin Endocrinol Metab. 2010 Jun;24(3):503-13. doi: 10.1016/j.beem.2010.01.005.
This article defines familial testicular germ cell tumours (FTGCTs) as testicular germ cell tumours (TGCTs) diagnosed in at least two blood relatives, a situation which occurs in 1-2% of all cases of TGCT. Brothers and fathers of TGCT patients have an 8-10- and 4-6-fold increased risk of TGCT, respectively, and an even higher elevated risk of TGCT in twin brothers of men with TGCT has been observed, suggesting that genetic elements play an important role in these tumours. Nevertheless, previous linkage studies with multiple FTGCT families did not uncover any high-penetrance genes and it has been concluded that the combined effects of multiple common alleles, each conferring a modest risk, might underlie FTGCT. In agreement with this assumption, recent candidate gene-association analyses have identified the chromosome Y gr/gr deletion and mutations in the PDE11A gene as genetic modifiers of FTGCT risk. Moreover, two genome-wide association studies of predominantly sporadic but also familial cases of TGCT have identified three additional susceptibility loci, KITLG, SPRY4 and BAK1. Notably, all five loci are involved in the biology of primordial germ cells, representing the cell of origin of TGCT, suggesting that the tumours arise as a result of disturbed testicular development.
本文将至少有两名血缘亲属确诊的睾丸生殖细胞肿瘤(TGCT)定义为家族性睾丸生殖细胞肿瘤(FTGCT),这种情况占所有 TGCT 病例的 1-2%。TGCT 患者的兄弟和父亲患 TGCT 的风险分别增加了 8-10 倍和 4-6 倍,而 TGCT 男性的双胞胎兄弟患 TGCT 的风险甚至更高,这表明遗传因素在这些肿瘤中起着重要作用。然而,先前对多个 FTGCT 家族进行的连锁研究并未发现任何高外显率基因,因此得出结论,多个常见等位基因的共同作用,每个基因赋予适度的风险,可能是 FTGCT 的基础。与这一假设一致,最近的候选基因关联分析已经确定了染色体 Ygr/gr 缺失和 PDE11A 基因突变是 FTGCT 风险的遗传修饰因子。此外,两项主要针对散发性但也包括家族性 TGCT 病例的全基因组关联研究已经确定了另外三个易感位点:KITLG、SPRY4 和 BAK1。值得注意的是,所有五个位点都参与原始生殖细胞的生物学,代表 TGCT 的起源细胞,这表明肿瘤是由于睾丸发育紊乱而产生的。